I-CBP112 showed inhibitory effects on cancer cell growth in both human and mouse MLL-AF9 AML cell lines and prolonged the survival of mice injected with MLL-AF9 AML cells. The gene discussed is KMT2A; the disease is acute myeloid leukemia.